Clinical Trials in Texas

Showing 1881-1900 of 12,973 trials

Data Collection for the Validation of an Artificial Intelligence Software to Support Musculoskeletal Ultrasound Examination

NCT07336407

This study conducted at three locations, aiming to collect ultrasound images from volunteers and assess the performance of an AI software, MSK Go, using these images. The software to be assessed is designed to assist physicians and healthcare professionals in performing ultrasound exams by classifying scan views and identifying key anatomical structures during a musculoskeletal ultrasound examination. The main question the study aims to answer is whether the AI software performs safely and effectively for future clinical use.

Ultrasound Imaging of Anatomical Structures

Smart Alfa Teknoloji San. ve Tic. A.S.79 participantsStarted Sep 2025

La Jolla, California, United States • Brooklyn, New York, United States • Woodland, Texas, United States

Active Not RecruitingPhase 338 miles

A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)

NCT06172257

The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of OCS 01 as compared to Vehicle in participants with Diabetic Macular Edema (DME).

Diabetic Macular Edema

Oculis401 participantsStarted Mar 2024

Gilbert, Arizona, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +59 more locations

Data Collection for the Validation of an Artificial Intelligence Software to Support Musculoskeletal Ultrasound Examination

A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)

Find Trials by Condition in Texas

A Single Arm Study Evaluating the Efficacy, Safety and Tolerability of Ofatumumab in Patients With Relapsing Multiple Sclerosis

Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents

Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis

A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies

Study of ENV-294 in Healthy Adults and in Adults With Moderate-to-Severe Atopic Dermatitis

Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure

A Study in Patients With Mixed Dyslipidemia

Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH

A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)

A Study of MBG453 in Combination With Hypomethylating Agents in Subjects With IPSS-R Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS).

Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

ALRN-6924 in Patients With Advanced Solid Tumors or Lymphomas

Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIV

A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)

PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma

Single Arm, Open Label Trial With Iptacopan Treatment for 24 Weeks, in Patients on Stable Regimen of Anti-C5 Who Switch to Iptacopan.

Liver Cirrhosis Network Cohort Study